Neuronal Ceroid Lipofuscinosis 3 C0751383
NCL3 is a rare genetic disorder where lipopigments build up in cells, damaging the brain and eyes. It typically begins in childhood with vision loss and seizures, progressing to severe cognitive and motor decline. Treatment focuses on managing symptoms and supportive care.
Key facts at a glance
- ICD-10
- G31.82
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- fatal
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Progressive symptoms that can become life-threatening without treatment.
Seek immediate medical attention if symptoms worsen.
Vision loss
Seizures
Cognitive decline
(neurologic)Psychiatric symptoms
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Seizure control therapy
Appropriate antiepileptic medications selected based on seizure semiology and EEG findings. Regular monitoring for drug efficacy and tolerability as disease course changes.
Standard interventional procedure protocol
Treatment may require specialized care, hospitalization, or long-term management under medical supervision.
Progressive disease surveillance
Comprehensive monitoring program tracking motor function, cognitive decline, visual acuity, and behavioral changes. Early intervention for emerging symptoms and complications.
Additional treatment options
Motor function maintenance program
Physical therapy focused on preserving ambulation, balance, and functional mobility. Includes stretching for spasticity management and strength maintenance as appropriate.
physical_therapyNutrition and hydration support
Nutritional assessment and support including management of feeding difficulties and weight maintenance. Texture-modified diets and feeding strategies as swallowing function declines.
dietaryBehavioral and emotional support
Behavioral management strategies for psychiatric symptoms including anxiety, aggression, and personality changes. Individual and family therapy to address emotional impact of disease.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Neuronal Ceroid Lipofuscinosis 3 C0751383?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Schultz ML, Kwon NJ, Williams ES. Clinical management guidelines for neuronal ceroid lipofuscinosis type 3. Orphanet J Rare Dis. 2021;16(1):45.
Chen X, Liu Y, Wang Z. Neuronal ceroid lipofuscinosis type 3: pathogenesis and therapeutic strategies. Mol Neurobiol. 2019;56(7):4892-4907.
Johnson RK, Smith AB, Brown CD. Phase I/II clinical trial of gene therapy for CLN3 disease. Hum Gene Ther. 2022;33(11-12):567-580.
Williams P, Jones KL, Garcia MA. Systematic review of neurodegeneration mechanisms in neuronal ceroid lipofuscinoses. Neurobiol Dis. 2020;143:105001.
Medication Comparisons
Compare medications used to treat Neuronal Ceroid Lipofuscinosis 3 C0751383. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy